Melatonin: A novel indolamine in oral health and disease

12Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This paper attempts to summarise the findings accumulated within the last few years concerning the hormone of darkness melatonin. Based on its origin, from the pineal gland until recently it was portrayed exclusively as a hormone. Due to its lipophilic nature, it is accessible to every cell. Thus, in the classic sense it is a cell protector rather than a hormone. Recent studies, by Claustrat et al. (2005), detected few extrapineal sources of melatonin like retina, gastrointestinal tract, and salivary glands. Due to these sources, research by Cutando et al. (2007), is trying to explore the implications of melatonin in the oral cavity, in addition to its physiologic anti-oxidant, immunomodulatory and oncostatic functions at systemic level that may be receptor dependent or independent. Recently, certain in vivo studies by Shimozuma et al. (2011), detected the secretion of melatonin from salivary glands further emphasising its local activity. Thus, within our confines the effects of melatonin in the mouth are reviewed, adding a note on therapeutic potentials of melatonin both systemically and orally. Copyright © 2012 V. K. Chava and K. Sirisha.

Cite

CITATION STYLE

APA

Chava, V. K., & Sirisha, K. (2012). Melatonin: A novel indolamine in oral health and disease. International Journal of Dentistry. https://doi.org/10.1155/2012/720185

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free